Skip to main content

Pfizer Inc

SEC CIK
0000078003
Latest filing
Aug 13, 2026

Holdings in Q4 2025

Holdings as of Dec 31, 2025, filed Feb 12, 2026. Long positions only; changes compare share counts with Q3 2025.

Institution overview
Positions
18
−3 vs. Q3 2025
Portfolio value
$236.5M
−$201.0M (−45.9%) vs. Q3 2025
Filed
Feb 12, 2026
SEC
Holdings of Pfizer Inc in Q4 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
ORICOric Pharmaceuticals, Inc.COM5,376,344$44.0M18.6%00.0%UnchangedHistory
ARVNArvinas, Inc.COM3,457,815$41.0M17.3%00.0%UnchangedHistory
CELCCelcuity Inc.COM349,406$34.8M14.7%00.0%UnchangedHistory
WVEWave Life Sciences, Inc.SHS1,875,000$31.9M13.5%00.0%UnchangedHistory
ALLOAllogene Therapeutics, Inc.COM22,032,040$30.2M12.8%00.0%UnchangedHistory
ZURAZura Bio LtdCLASS A ORD SHS2,970,022$15.6M6.6%00.0%UnchangedHistory
PYXSPyxis Oncology, Inc.COMMON STOCK7,032,770$8.09M3.4%00.0%UnchangedHistory
CRBUCaribou Biosciences, Inc.COM4,690,431$7.46M3.2%00.0%UnchangedHistory
CRDFCardiff Oncology, Inc.COM2,411,575$6.78M2.9%00.0%UnchangedHistory
BHVNBiohaven Ltd.COM505,645$5.71M2.4%00.0%UnchangedHistory
SPROSpero Therapeutics, Inc.COM2,362,348$5.50M2.3%00.0%UnchangedHistory
NXTCNextCure, Inc.COM NEW157,646$2.24M0.9%00.0%UnchangedHistory
ZNTLZentalis Pharmaceuticals, Inc.COM953,834$1.29M0.5%00.0%UnchangedHistory
QTTBQ32 Bio Inc.COM277,777$922.2K0.4%00.0%UnchangedHistory
ANTXAN2 Therapeutics, Inc.COM715,295$815.4K0.3%00.0%UnchangedHistory
BOLTBolt Biotherapeutics, Inc.COM NEW31,305$171.2K0.1%00.0%UnchangedHistory
DNAGinkgo Bioworks Holdings, Inc.CL A NEW2,928$24.3K<0.1%00.0%UnchangedHistory
SENSSenseonics Holdings, Inc.COM2,171$12.0K<0.1%00.0%UnchangedConverted for a 1-for-20 splitHistory

Sold out since Q3 2025 (3)

Positions held at the end of Q3 2025 that are gone from this filing.

Positions of Pfizer Inc sold out since Q3 2025
SecurityClassShares in Q3 2025Value in Q3 2025% of portfolio in Q3 2025History
BNTXBioNTech SESPONSORED ADS1,658,361$163.5M37.4%History
TRMLTourmaline Bio, Inc.COM1,272,214$60.8M13.9%History
EPIXESSA Pharma Inc.COM NEW1,675,000$319.9K0.1%History